Company Financials
Diaceutics plc Financials
Pound sterling
business
Diaceutics plc Company Profile
Main Stock Listing
LSE: DXRX
Market Capitalization £124.2 Million as of Jan. 1, 2025
Market Cap History
Valuations Metrics as of May. 5, 2024
| Trailing PE | 105.00 |
| Forward PE | -40.50 |
| Price to Sales TTM | £3.85 |
| Price to Book MRQ | £201.23 |
| Enterprise to Revenue | 3.01 |
| Enterprise to EBITDA | 49.72 |
Financial Reports as of Jun. 30, 2023
Financials
| Fiscal Year Ends | 2022-12-31 |
| Most Recent Quarter | 2023-06-30 |
| Profit Margin | 0.03% |
| Operating Margin | -21.83% |
| Return on Assets TTM | -0.72% |
| Return on Equity TTM | 0.01% |
Income Statement
| Revenue TTM | £21,900,000 |
| Revenue per Share TTM | £0.26 |
| Quarterly Revenue Growth | 31.80% |
| Gross Profit TTM | £16,741,000 |
| EBITDA | £3,692,000 |
| Net Income to Common TTM | £6,000 |
| Diluted EPS TTM | £0.01 |
| Quarterly Earnings Growth YoY | % |
Balance Sheet
| Total Cash MRQ | £17,880,000 |
| Total Cash per Share MRQ | £0.21 |
| Total Debt MRQ | £ |
| Total Debt to Equity MRQ | 3.07 |
| Current Ratio MRQ | 7.99 |
| Book Value per Share MRQ | £0.49 |
Cash Flow
| Operating Cash Flow TTM | £2,530,000 |
| Levered Free Cash Flow TTM | £-2,313,750 |
DXRX Stock Info as of May. 5, 2024
Stock Statistics
| Shares Outstanding | 84,679,296 |
| Float Shares | 48,048,807 |
| Avg 10 Volume | 36,817 |
| Avg 30 Volume | None |
| Shares Short | None |
| Short Ratio | |
| Short % of Shares | % |
| % Held by Insiders | 34.54% |
| % Held by Institutions | 53.24% |
Stock Price Summary
| Beta | 0.45 |
| Fifty Two Week Low | £79.00 |
| Fifty Two Week High | £110.00 |
| Fifty Two Week Change | 1.02% |
| Day 50 MA | £101.66 |
| Day 200 MA | £97.36 |
Dividends and Splits
| Forward Annual Dividend Rate | £ |
| Forward Annual Dividend Yield | % |
| Trailing Annual Dividend Rate | £0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Dividend Date | |
| Ex Dividend Date | |
| Last Split Factor | |
| Last Split Date |